PROGENICS PHARMACEUTICALS INC
PROGENICS PHARMACEUTICALS INC (PGNX) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 800 transactions totaling $38.6M, demonstrating a bearish sentiment with -$14.8M in net insider flow. The most recent transaction on Jun 19, 2020 involved a transaction of 12,000 shares valued at $0.
PGNX Insider Activity Summary
Who Is Buying PGNX Stock?
No significant insider buying has been recorded for PGNX in the recent period.
Who Is Selling PGNX Stock?
No significant insider selling has been recorded for PGNX in the recent period.
Is PROGENICS PHARMACEUTICALS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PGNX is bearish with an Insider Alignment Score of 31/100 and a net flow of -$14.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
PGNX Frequently Asked Questions
Understanding PGNX Insider Activity
Insider trading at PROGENICS PHARMACEUTICALS INC (PGNX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading PGNX stock, having executed 800 transactions in the past 90 days. The most active insider is Paul J. Maddon (Executive), who has made 148 transactions totaling $15.3M.
Related Tools
Track PROGENICS PHARMACEUTICALS INC Insider Activity
Get notified when executives and directors at PGNX file new Form 4 transactions